poisar

Stocks · News reference

Ukraine's Ministry Of Health Accepts Valion Bio's Regulatory Dossier For Entolimod For Formal Review Under Regulatory Equivalence Pathway

BenzingaJul 22, 2026, 11:47 AMBenzinga Newsdesk

Valion Bio, Inc. (NASDAQ:VBIO) today announced that Ukraine's Ministry of Health (MoH) has accepted the Company's regulatory dossier for Entolimod—a medical countermeasure for Acute Radiation Syndrome (ARS)—for

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 22, 2026, 11:47 AM
Checked
Jul 22, 2026, 11:47 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 27, 2026, 12:30 PMSEC EDGAR

    8-K filing — Valion Bio, Inc. (VBIO)

    Filed: 2026-08-27 AccNo: 0001683168-26-006742 Size: 244 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar